Guideline-recommended therapies for heart failure (HF) were found to be ineffective in patients with HF caused by Chagas ...

As the first immunotherapy option in this setting, the approval sets a new standard for resectable early-stage gastric and gastroesophageal junction (GEJ) cancers.